IL147891A0 - Topical use of anti-muscarnic agents - Google Patents

Topical use of anti-muscarnic agents

Info

Publication number
IL147891A0
IL147891A0 IL14789100A IL14789100A IL147891A0 IL 147891 A0 IL147891 A0 IL 147891A0 IL 14789100 A IL14789100 A IL 14789100A IL 14789100 A IL14789100 A IL 14789100A IL 147891 A0 IL147891 A0 IL 147891A0
Authority
IL
Israel
Prior art keywords
muscarnic
agents
topical use
topical
muscarnic agents
Prior art date
Application number
IL14789100A
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of IL147891A0 publication Critical patent/IL147891A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14789100A 1999-08-09 2000-08-07 Topical use of anti-muscarnic agents IL147891A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9918760.1A GB9918760D0 (en) 1999-08-09 1999-08-09 Topical treatment
PCT/GB2000/003032 WO2001010427A2 (en) 1999-08-09 2000-08-07 Use of anti-muscarinic agents for treating skin disorders

Publications (1)

Publication Number Publication Date
IL147891A0 true IL147891A0 (en) 2002-08-14

Family

ID=10858850

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14789100A IL147891A0 (en) 1999-08-09 2000-08-07 Topical use of anti-muscarnic agents

Country Status (8)

Country Link
EP (1) EP1202723A2 (en)
JP (1) JP2003506405A (en)
AU (1) AU6306400A (en)
CA (1) CA2378445A1 (en)
GB (1) GB9918760D0 (en)
IL (1) IL147891A0 (en)
WO (1) WO2001010427A2 (en)
ZA (1) ZA200200795B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004402A1 (en) * 2000-07-11 2002-01-17 Banyu Pharmaceutical Co., Ltd. Ester derivatives
DE10111843A1 (en) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Compounds for the treatment of inflammatory diseases
DE102004016179A1 (en) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Compounds for the treatment of proliferative processes
WO2006054312A1 (en) * 2004-11-16 2006-05-26 Munisekhar Medasani Ammonium compounds for treating psoriasis and eczema
WO2007071313A2 (en) * 2005-12-21 2007-06-28 Meda Pharma Gmbh & Co Kg Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases
GB0611240D0 (en) * 2006-06-07 2006-07-19 Daniolabs Ltd The treatment of increased sebum production
WO2009068876A1 (en) * 2007-11-30 2009-06-04 Summit Corporation Plc Compositions for the treatment of skin disorders
WO2009150408A2 (en) * 2008-06-13 2009-12-17 Summit Corporation Plc Topical antimuscarinic formulations
CN105026369A (en) 2013-02-28 2015-11-04 德米拉股份有限公司 Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
EP3288527B1 (en) 2015-04-28 2020-02-19 Unilever PLC, a company registered in England and Wales under company no. 41424 of N-aralkylcarbonyldiamine compounds and personal care compositions comprising the same
CN107531655B (en) 2015-04-28 2021-03-12 荷兰联合利华有限公司 N-aralkylcarbonyl-piperazine and N-aralkylcarbonyl-homopiperazine compounds and personal care compositions containing the same
CN112730821B (en) * 2019-10-14 2024-04-09 泰州医药城国科化物生物医药科技有限公司 Method for analyzing long-acting property of receptor antagonist
CN110898227A (en) * 2019-11-04 2020-03-24 上海交通大学医学院附属瑞金医院卢湾分院 Combined medicine for treating psoriasis and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19626373A1 (en) * 1996-07-02 1998-01-08 Boehringer Ingelheim Kg Novel use of active ingredients that affect the function of non-neuronal acetylcholine
US6011022A (en) * 1998-03-03 2000-01-04 El Khoury; George F. Topical application of muscarinic analgesic drugs such as neostigmine

Also Published As

Publication number Publication date
WO2001010427A2 (en) 2001-02-15
AU6306400A (en) 2001-03-05
JP2003506405A (en) 2003-02-18
ZA200200795B (en) 2003-03-26
GB9918760D0 (en) 1999-10-13
WO2001010427A3 (en) 2001-09-20
EP1202723A2 (en) 2002-05-08
CA2378445A1 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
IL147296A0 (en) Imidazoimidazoles and triazoles as anti-inflammatory agents
GB9911863D0 (en) Therapeutic agents
GB9905010D0 (en) Therapeutic agents
IL150030A0 (en) Therapeutic agents
GB9904786D0 (en) Therapeutic agents
PL355101A1 (en) Use of h1
GB9929685D0 (en) Therapeutic agents
HK1050840A1 (en) Topical skin composition
GB9929687D0 (en) Therapeutic agents
IL147891A0 (en) Topical use of anti-muscarnic agents
GB9921351D0 (en) Therapeutic agents
GB9911881D0 (en) Therapeutic agents
GB9929569D0 (en) Therapeutic agents
GB9903476D0 (en) Therapeutic agents
GB9914744D0 (en) Therapeutic agents
GB9903119D0 (en) Therapeutic agents
GB9914742D0 (en) Therapeutic agents
GB9914745D0 (en) Therapeutic agents
PL350963A1 (en) Use of arylalkanoylpyridazines
GB9902881D0 (en) Therapeutic agents
GB9914743D0 (en) Therapeutic agents
GB9901444D0 (en) Anti-inflammatory agents
GB9915616D0 (en) Therapeutic agents
GB9906124D0 (en) Therapeutic agent
GB9911238D0 (en) Therapeutic use